Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2020-01-24
Product name
GSK3326595D CAPSULES
Product Synonyms
GSK3326595D, FORMULATED PRODUCT
1.2.1 Relevant identified uses
Investigational Medicinal Product
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Reproductive toxicity Category 2 Specific target organ toxicity following Category 1 repeated exposure
Environmental hazards
Not classified.
Signal word
Danger
Hazard statements
Suspected of damaging fertility or the unborn child. Causes damage to organs through prolonged or repeated exposure.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Wear protective gloves/protective clothing/eye protection/face protection.
Response
IF exposed or concerned: Get medical advice/attention.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
3 % of the mixture consists of component(s) of unknown acute oral toxicity. 15.83 % of the mixture consists of component(s) of unknown acute dermal toxicity. 15.83 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 15.83 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
